Vascepa is a prescription medication that contains the active ingredient eicosapentaenoic acid (EPA), which is a type of omega-3 fatty acid that is found in fish oil. It is approved by the FDA to reduce triglyceride levels in adults with severe hypertriglyceridemia [1].

Statins are a class of medications that are used to lower cholesterol levels in the blood. They work by blocking an enzyme that is necessary for the production of cholesterol in the liver. While statins are generally well-tolerated, they can cause side effects in some people, such as muscle pain, liver damage, and digestive problems [3].

There is limited research on whether Vascepa can reduce statin side effects. However, one study published in the American Journal of Cardiology found that adding Vascepa to statin therapy in patients with high triglyceride levels reduced the incidence of muscle-related adverse events [2].

It is important to note that Vascepa is not a substitute for statin therapy in people who need to lower their cholesterol levels. Statins are the first-line treatment for high cholesterol, and they have been shown to reduce the risk of heart attack and stroke in people with cardiovascular disease [3].

In conclusion, while there is some evidence to suggest that Vascepa may reduce muscle-related side effects of statin therapy, more research is needed to confirm this finding. It is important for people with high cholesterol to work with their healthcare provider to determine the best treatment plan for their individual needs [1][2][3].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.ajconline.org/article/S0002-9149(16)31111-0/fulltext
[3] https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/cholesterol-medications/art-20050958